GENEVA, May 15 -- AMGEN INC. (One Amgen Center DriveThousand Oaks, California 91320-1799) filed a patent application (PCT/US2024/053984) for "FIBROBLAST TARGETING MOLECULES" on Oct 31, 2024. With publication no. WO/2025/096842, the details related to the patent application was published on May 08, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): TAKENAKA, Shunsuke (c/o AMGEN INC.Law Dept. - Patent OperationsOne Amgen Center Drive, MS 28-5-AThousand Oaks, California 91320-1799), YAO, Qing (c/o AMGEN INC.Law Dept. - Patent OperationsOne Amgen Center Drive, MS 28-5-AThousand Oaks, California 913...